|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/46 | |
| A61P 35/00 | |||
| C07H 21/04 | |||
| C12N 1/21 | |||
| C12N 15/63 | |||
| C12N 9/82 | |||
| C12P 1/04 |
| (11) | Patento numeris | 2046369 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 07840229.4 |
| Europos patento paraiškos padavimo data | 2007-06-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2009-04-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-08-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2007/070706 |
| Data | 2007-06-08 |
| (87) | Numeris | WO 2008/011234 |
| Data | 2008-01-24 |
| (30) | Numeris | Data | Šalis |
| 817817 P | 2006-06-30 | US |
| (72) |
FILPULA, David R., US
WANG, Maoliang, US
|
| (73) |
Sigma-Tau Pharma Limited,
21 Holborn Viaduct, London EC1A 2DY,
GB
|
| (54) | RECOMBINANT HOST FOR PRODUCING L-ASPARAGINASE II |
| RECOMBINANT HOST FOR PRODUCING L-ASPARAGINASE II |